Article Details

Glenmark partners with Pfizer to launch abrocitinib in India to treat atopic dermatitis

Retrieved on: 2024-01-31 21:42:19

Tags for this article:

Click the tags to see associated articles and topics

Glenmark partners with Pfizer to launch abrocitinib in India to treat atopic dermatitis. View article details on hiswai:

Excerpt

Glenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and CIBINQO. Developed by Pfizer, abrocitinib has received ...

Article found on: m.economictimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up